“Prevalence Of Obesity Among U.s. Population With Substance Dependence.”. Drug Alcohol Depend 217. Drug Alcohol Depend: 108293. doi:10.1016/j.drugalcdep.2020.108293. https://pubmed.ncbi.nlm.nih.gov/32980787/#affiliation-4.
. 2020. “Implementation Facilitation To Promote Emergency Department-Initiated Buprenorphine For Opioid Use Disorder: Protocol For A Hybrid Type Iii Effectiveness-Implementation Study (Project Ed Health).”. Implement Sci 14 (1). Implement Sci: 48. doi:10.1186/s13012-019-0891-5.
. 2019. “Thrombosis Risk Factors In Pik3Ca-Related Overgrowth Spectrum And Proteus Syndrome.”. Am J Med Genet C Semin Med Genet 181 (4). Am J Med Genet C Semin Med Genet: 571-581. doi:10.1002/ajmg.c.31735.
. 2019. “Testing And Linkage To Hiv Care In China: A Cluster-Randomised Trial.”. Lancet Hiv 4 (12). Lancet Hiv: e555-e565. doi:10.1016/S2352-3018(17)30131-5.
. 2017. “Effect Of Patient Navigation With Or Without Financial Incentives On Viral Suppression Among Hospitalized Patients With Hiv Infection And Substance Use: A Randomized Clinical Trial.”. Jama 316 (2). Jama: 156-70. doi:10.1001/jama.2016.8914.
. 2016. “Hair Analysis And Its Concordance With Self-Report For Drug Users Presenting In Emergency Department.”. Drug Alcohol Depend 167. Drug Alcohol Depend: 149-55. doi:10.1016/j.drugalcdep.2016.08.007.
. 2016. “Assessment Of Immature Platelet Fraction In The Diagnosis Of Wiskott-Aldrich Syndrome.”. Front Pediatr 3. Front Pediatr: 49. doi:10.3389/fped.2015.00049.
. 2015. “Rationale For Using Exercise In The Treatment Of Stimulant Use Disorders.”. J Glob Drug Policy Pract 6 (1). J Glob Drug Policy Pract.
. 2012. “Study Design To Examine The Potential Role Of Assessment Reactivity In The Screening, Motivational Assessment, Referral, And Treatment In Emergency Departments (Smart-Ed) Protocol.”. Addict Sci Clin Pract 7. Addict Sci Clin Pract: 16. doi:10.1186/1940-0640-7-16.
. 2012. “Stimulant Reduction Intervention Using Dosed Exercise (Stride) - Ctn 0037: Study Protocol For A Randomized Controlled Trial.”. Trials 12. Trials: 206. doi:10.1186/1745-6215-12-206.
. 2011. “Score Study Report 8: Closed Tests For All Pair-Wise Comparisons Of Means.”. Drug Inf J 44 (4). Drug Inf J: 405-420. doi:10.1177/009286151004400405.
. 2010. “Results Of An Elispot Proficiency Panel Conducted In 11 Laboratories Participating In International Human Immunodeficiency Virus Type 1 Vaccine Trials.”. Aids Res Hum Retroviruses 21 (1). Aids Res Hum Retroviruses: 68-81. doi:10.1089/aid.2005.21.68.
. 2005. “Standardization And Validation Issues Of The Elispot Assay.”. Methods Mol Biol 302. Methods Mol Biol: 51-86. doi:10.1385/1-59259-903-6:051.
. 2005.